Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

643 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Publisher Correction: High-throughput fluorescence lifetime imaging flow cytometry.
Kanno H, Hiramatsu K, Mikami H, Nakayashiki A, Yamashita S, Nagai A, Okabe K, Li F, Yin F, Tominaga K, Bicer OF, Noma R, Kiani B, Efa O, Büscher M, Wazawa T, Sonoshita M, Shintaku H, Nagai T, Braun S, Houston JP, Rashad S, Niizuma K, Goda K. Kanno H, et al. Among authors: mikami h. Nat Commun. 2025 Jan 10;16(1):582. doi: 10.1038/s41467-025-55961-4. Nat Commun. 2025. PMID: 39794325 Free PMC article. No abstract available.
Clinically Significant Prostate Cancer Prediction Using Multimodal Deep Learning with Prostate-Specific Antigen Restriction.
Takeda H, Akatsuka J, Kiriyama T, Toyama Y, Numata Y, Morikawa H, Tsutsumi K, Takadate M, Hasegawa H, Mikami H, Obayashi K, Endo Y, Takahashi T, Fukumoto M, Ohashi R, Shimizu A, Kimura G, Kondo Y, Yamamoto Y. Takeda H, et al. Among authors: mikami h. Curr Oncol. 2024 Nov 15;31(11):7180-7189. doi: 10.3390/curroncol31110530. Curr Oncol. 2024. PMID: 39590160 Free PMC article.
The Current Status of Comprehensive Genomic Profiling in the Management of Metastatic Castration-Resistant Prostate Cancer: A Study from a Cooperative Hospital for Cancer Genomic Medicine in Japan.
Akatsuka J, Kimura G, Takadate M, Hiraoka S, Sahara T, Iwai T, Hasegawa H, Mikami H, Obayashi K, Takeda H, Endo Y, Toyama Y, Yamamoto Y, Yamada T, Kondo Y. Akatsuka J, et al. Among authors: mikami h. J Nippon Med Sch. 2024;91(5):472-479. doi: 10.1272/jnms.JNMS.2024_91-512. J Nippon Med Sch. 2024. PMID: 39505505 Free article.
High-throughput fluorescence lifetime imaging flow cytometry.
Kanno H, Hiramatsu K, Mikami H, Nakayashiki A, Yamashita S, Nagai A, Okabe K, Li F, Yin F, Tominaga K, Bicer OF, Noma R, Kiani B, Efa O, Büscher M, Wazawa T, Sonoshita M, Shintaku H, Nagai T, Braun S, Houston JP, Rashad S, Niizuma K, Goda K. Kanno H, et al. Among authors: mikami h. Nat Commun. 2024 Sep 4;15(1):7376. doi: 10.1038/s41467-024-51125-y. Nat Commun. 2024. PMID: 39231964 Free PMC article.
snRNAs from Radical Prostatectomy Specimens Have the Potential to Serve as Prognostic Factors for Clinical Recurrence after Biochemical Recurrence in Patients with High-Risk Prostate Cancer.
Mikami H, Noguchi S, Akatsuka J, Hasegawa H, Obayashi K, Takeda H, Endo Y, Toyama Y, Takei H, Kimura G, Kondo Y, Takizawa T. Mikami H, et al. Cancers (Basel). 2024 May 1;16(9):1757. doi: 10.3390/cancers16091757. Cancers (Basel). 2024. PMID: 38730709 Free PMC article.
Engineering CD3/CD137 Dual Specificity into a DLL3-Targeted T-Cell Engager Enhances T-Cell Infiltration and Efficacy against Small-Cell Lung Cancer.
Mikami H, Feng S, Matsuda Y, Ishii S, Naoi S, Azuma Y, Nagano H, Asanuma K, Kayukawa Y, Tsunenari T, Kamikawaji S, Iwabuchi R, Shinozuka J, Yamazaki M, Kuroi H, Ho SSW, Gan SW, Chichili P, Pang CL, Yeo CY, Shimizu S, Hironiwa N, Kinoshita Y, Shimizu Y, Sakamoto A, Muraoka M, Takahashi N, Kawa T, Shiraiwa H, Mimoto F, Kashima K, Kamata-Sakurai M, Ishikawa S, Aburatani H, Kitazawa T, Igawa T. Mikami H, et al. Cancer Immunol Res. 2024 Jun 4;12(6):719-730. doi: 10.1158/2326-6066.CIR-23-0638. Cancer Immunol Res. 2024. PMID: 38558120
643 results